
To understand the disease mechanisms at work in ALS, our first objective was to perform clinical research and study the natural disease course of ALS. This strategy led to the first successful clinical trial in 1994. Beside our current involvement with clinical trials, we acquired an expertise in muscle biomarkers, genetics and neuroimaging.
Contact
LocationHôpital de la Salpêtrière, Boulevard de l'Hopital, Paris, France
Contact